A critical advance in cancer investigation is occurring with the use of VHH fragments to reactivate dysfunctional p53. This vital tumor inhibitor protein is frequently inactivated in various types of cancer, causing https://social40.com/story7535251/mini-antibodies-restore-p53-a-promising-approach-for-malignant-treatment